A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
Clinical trial NCT05394805 · COMPLETED
Trial details
- NCT number
- NCT05394805
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-29
- Primary completion
- 2024-12-26
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.